Literature DB >> 30262199

Using 99mTc-DTPA galactosyl human serum albumin liver scintigraphy as a prognostic indicator in jaundice-free patients with biliary atresia.

Masaki Nio1, Motoshi Wada2, Hideyuki Sasaki2, Hiromu Tanaka2, Megumi Nakamura2, Hironori Kudo2.   

Abstract

BACKGROUND: We evaluated the clinical significance of follow-up data, including 99mTc-DTPA galactosyl human serum albumin (99mTc-GSA) liver scintigraphy data, as prognostic indicators for jaundice-free patients with biliary atresia (BA).
METHODS: Of 87 patients who underwent Kasai portoenterostomy (KP) between 1991 and 2012, 45 jaundice-free patients aged 1-2 years underwent 99mTc-GSA scintigraphy and were classified into 2 groups: those who survived with a native liver (Group A, n = 34) and those who required liver transplantation (LTx) (Group B, n = 11). We compared 99mTc-GSA scintigraphy data (HH15, LHL15, and HH15/LHL15 [H/L15]) and liver function test (LFT) results between the groups. The patients underwent a second 99mTc-GSA scintigraphy at approximately 5 years of age.
RESULTS: All patients survived. HH15, H/L15, total bilirubin, direct bilirubin, gamma-glutamyl transpeptidase, and alanine transaminase levels were higher in Group B than in Group A (p<0.05). Total and direct bilirubin levels were associated with H/L15 (p<0.05). There were no significant changes in results between the first and second 99mTc-GSA scintigraphy in Group A.
CONCLUSIONS: Mid- and long-term prognoses may be predicted using 99mTc-GSA scintigraphy data and LFTs in patients aged 1-2 years. We recommend regular monitoring of postoperative data following KP, even in jaundice-free patients. LEVEL OF EVIDENCE: III.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  (99m)Tc-GSA liver scintigraphy; Biliary atresia; Functional hepatic reserve; Kasai portoenterostomy; Prognostic factor

Mesh:

Substances:

Year:  2018        PMID: 30262199     DOI: 10.1016/j.jpedsurg.2018.08.032

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  4 in total

1.  Imaging prediction with ultrasound and MRI of long-term medical outcome in native liver survivor patients with biliary atresia after kasai portoenterostomy: a pilot study.

Authors:  Martina Caruso; Fabiola Di Dato; Carmine Mollica; Gianfranco Vallone; Valeria Romeo; Raffaele Liuzzi; Pier Paolo Mainenti; Mario Petretta; Raffaele Iorio; Arturo Brunetti; Simone Maurea
Journal:  Abdom Radiol (NY)       Date:  2021-02-02

2.  Microvascular proliferation of the portal vein branches in the liver of biliary atresia patients at Kasai operation is associated with a better long-term clinical outcome.

Authors:  Toshio Harumatsu; Toshihiro Muraji; Ryuta Masuya; Haruo Ohtani; Taichiro Nagai; Keisuke Yano; Shun Onishi; Koji Yamada; Waka Yamada; Makoto Matsukubo; Mitsuru Muto; Tatsuru Kaji; Satoshi Ieiri
Journal:  Pediatr Surg Int       Date:  2019-09-21       Impact factor: 1.827

3.  Short- and long-term outcomes after Kasai operation for type III biliary atresia: Twenty years of experience in a single tertiary Egyptian center-A retrospective cohort study.

Authors:  Emad Hamdy Gad; Yasmin Kamel; Tahany Abdel-Hameed Salem; Mohammed Abdel-Hafez Ali; Ahmed Nabil Sallam
Journal:  Ann Med Surg (Lond)       Date:  2021-01-23

4.  Impacts of Early Kasai Portoenterostomy on Short-Term and Long-Term Outcomes of Biliary Atresia.

Authors:  Ryuji Okubo; Masaki Nio; Hideyuki Sasaki
Journal:  Hepatol Commun       Date:  2020-11-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.